только для медицинских специалистов

Консультант врача

Электронная медицинская библиотека

Раздел 2 / 2
Страница 1 / 1

Литература

  1. Aparicio J., Garciadel Muro X., Maroto P. et al. Spanish Germ Cell Cancer Cooperative Group (GG). Multicenter study evaluating a dual policy of postorchiectomy surveillance and selective adjuvant singliagent carboplatin for patients with clinical stage I seminoma // Ann. Oncol. — 2003. — Vol. 14. — Р. 867–872.
  2. Bockrath J.M., Schaeffr A.J., Kiess M.S., Nieman H.L. Ultrasound identifi cation of impalpable testicle tumor // J. Urol. — 1983. — Vol. 130. — Р. 355–356.
  3. Bosl G.J., Motzer R.J. Testicular germ cell cancer // N. Engl. J. Med. — 1997. — Vol. 337. — Р. 242–253.
  4. Cullen M.H., Stenning S.P., Parkinson M.C. et al. Short-course adjuvant chemotherapy in highrisk stage I nonseminomatous germ cell tumours of the testis: a Medical Research Council Report // J. Clin. Oncol. — 1996. — Vol. 14. — Р. 1106–1113.
  5. De Wit R., Stoter G., Kaye S.B. et al. Importance of bleomycin in combination chemotherapy for good-prognosis testicular nonseminoma: A randomized study of the European Organization for Research and Treatment of Cancer Genitourinary TractCancer Cooperative Group // J. Clin. Oncol. — 1997. — Vol. 15. — Р. 1837–1843.
  6. Debono D.J., Heilman D.K., Einhorn L.H., Donohue J.P. Decision analysis foravoiding postchemotherapy surgery in patients with disseminated nonseminomatousgerm cell tumors // J. Clin. Oncol. — 1997. — Vol. 15. — Р. 1455–1464.
  7. Dieckmann K.P., Loy V., Buttner P. Prevalence of bilateral germ cell tumors and early detection based on contralateral testicular intraepithelial neoplasia // Br. J. Urol. — 1993. — Vol. 71. — Р. 340–345.
  8. Doherty F.J. Ultrasound of the nonacute scrotum. In: Seminars in Ultrasound, CT and MRI / H.W. Raymond et al. (ed.). — New York: W.B. Saunders Co, 1991. — P. 131–156.
  9. Fossa S.D., Horwich A., Russell J.M. et al. Optimal planning target volume for stage I testicular seminoma: A Medical Research Council randomized trial // J. Clin. Oncol. — 1999. — Vol. 17. — Р. 1146–1154.

  1. Fossa S.D., Stenning S.P., Gerl A. et al. Prognostic factors in patients progressing after cisplatin-based chemotherapy for malignant nonseminomatous germcell tumours // Br. J. Cancer. — 1999. — Vol. 80. — Р. 1392–1399.
  2. Friedrich M., Claussen C.D., Felix R. Immersion ultrasound of testicular pathology // Radiology. — 1981. — Vol. 141. — Р. 235–237.
  3. Harland S.J., Cook P.A., Fossa S.D. et al. Intratubular germ cell neoplasia of contralateral testis in testicular cancer: defining high risk group // J. Urol. — 1998. — Vol. 160. — Р. 1353–1357.
  4. Heidenreich A., Moul J.W. Contralateral testicular biopsy procedure in patients with unilateral testis cancer: is it indicated? // Sem. Urol. Oncol. — 2002. — Vol. 20. — №4. — Р. 234–238.
  5. Horwich A., Bell J. Mortality and cancer incidence following treatment for seminoma of the testis // Radiother. Oncol. — 1994. — Vol. 30. — Р. 193–198.
  6. Huyghe E., Matsuda T., Thonneau P. Increasing incidence of testicular cancer worldwide: a review // J. Urol. — 2003. — Vol. 170. — №1. — Р. 5–11.
  7. Glazer H.S., Lee J.K. T., Melson G.L., McClennan B.L. Sonographic detection of occult testicular neoplasm // Am. J. Roentgenol. — 1982. — Vol. 138. — Р. 673–675.
  8. Johnson H.O., Mattrey R.F., Phillipson J. Differentiation of seminomatous from nonseminomatous testicular tumors by MRI // Am.J. Roentgenol. –1990. — Vol. 154. — Р. 539–543.
  9. Jones W.G., Fossa S.D., Mead G.M. et al. A randomized trial of two radiotherapy schedules in the adjuvant treatment of stage I seminoma (MRC TE 18) // E.J. Cancer. — 2001; 37 (1) abstract book: S. 157, abstract 572.
  10. Klein E.A. Tumor markers in testis cancer // Urol. Clin. North. Am. –1993. — Vol. 20. — Р. 67–73.
  11. Klepp O., Dahl O., Flodgren P., Stierner U. et al. Risk-аdapted treatment of clinical stage 1 nonseminoma testis cancer // Eur. J. Cancer. — 1997. — Vol. 33. — Р. 1038–1044.
  12. Laguna M.P., Klepp O., Horwich A. et al. Guidelines on testicular cancer // Update. — 2004, March.
  13. Lashley D.B., Lowe B.A. A rational approach to managing stage I nonseminomatous germ cell cancer // Urol. Clin. North. Am. — 1998. — Vol. 25. — Р. 405– 423.
  14. Loehrer P.J., Gonin R., Nichols C.R. et al. Vinblastine plus iofosfamide plus cisplatin as initial salvage therapy in recurrent germ cell tumor // J. Clin. Oncol. — 1998. — Vol. 16. — Р. 2500–2504.
  15. McGlynn K. A., Devesa S.S., Sigurdson A.J. et al. Trends in the incidence of testicular germ cell tumors in the United States // Cancer. — 2003. — Vol. 97. — №1. — Р. 63–70.
  16. Oliver R.T. D., Raja M.A., Ong J., Gallagher C.J. Pilot study to evaluateimpact of a policy of adjuvant chemotherapy for high risk stage I malignant teratoma on overall relapse rate of stage I cancer patients // J. Urol. — 1992. — Vol. 148. — Р. 1453–1456.
  17. Osterlind A., Berthelsen J.G., Abildgaard N. et al. Risk of bilateral testicular germ cell tumors in Denmark: 1960–1984 // J. Natl. Cancer. Inst. — 1991. — Vol. 83. — Р. 1391–1395.
  18. Richie J.P. Neoplasms of the testis. In: Campbell’s Urology / P.C. Walsh et al. (eds). — Philadelphia: WB Saunders Co., 1997. — P. 2411–2452.
  19. Saxman S., Finch D., Gonin R., Einhorn L.H. Long-term follow up of a phase III study of three versus four cycles of bleomycin, etoposide and cisplatin in favorable prognosis germcell tumors: the Indiana University Experience // J. Clin. Oncol. — 1998. — Vol. 16. — Р. 702–706.
  20. Schottenfeld D., Warshauer M.E., Sherlock S. et al. The epidemiology of testicular cancer in young adults // Am.J. Epidemiol. — 1980. — Vol. 112. — Р. 232– 246.
  21. Shawker T.H., Javadpour N., O’Leary T. et al. Ultrasonographic detection of burned out primary testicular germ cell tumors in clinically normal testes // J. Ultrasound. Med. — 1983. — Vol. 2. — Р. 477–479.
  22. Shelley M.D., Burgon K., Mason M.D. Treatment of testicular germ cellcancer: a Cochrane evidence-based systematic review // Cancer treatment reviews. — 2002. — Vol. 28. — P. 237–253.
  23. Sternberg C.N. The management of stage I testis cancer // Urol. Clin. North. Am. — 1998, Aug. — Vol. 25. — № 3. — Р. 435–449.
  24. Travis L.B., Curtis R.E., Storm H. et al. Risk of second malignant neoplasms among long-term survivors of testicular cancer // J. Natl. Cancer. Inst. — 1997. — Vol. 89. — Р. 1429–1439.
  25. Wanderas E.H., Tretli S., Fossa S.D. Trends in incidence of testicular cancer in Norway 1955–1992 // Eur.J. Cancer. — 1995. — Vol. 31A. — Р. 2044–2048.
  26. Warde P., Jewett M.A. S. Surveillance for stage I testicular seminoma. Is it a good option? // Urol. Clin. North. Am. — 1998. — Vol. 25. — Р. 425–433.
  27. Warde P., Specht L., Horwich A. et al. Prognostic factors for relapse in stage I seminoma managed by surveillance: a pooled analysis // J. Clin. Oncol. — 2002. — Vol. 20. — № 22. — Р. 4448–4452.
  28. Xiao H., Mazumdar M., Bajorin D.F. et al. Long-term follow-up of patients with good risk germ cell tumors treated with etoposide and cisplatin // J. Clin. Oncol. — 1997. — Vol. 15. — Р. 2553–2558.
  29. Злокачественные новообразования в России в 2014 г. (заболеваемость и смертность). Под ред. А.Д.Каприна, В.В.Старинского, Г.В.Петровой. М.2016г.